Patent assignee · US · COMPANY

VISOLIS, INC.

4Patents
4Active
4Granted
48Portfolio score

Filing activity: Nov 24, 2015 → Feb 8, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US10208008B2 Processes for conversion of biologically derived mevalonic acid Chemistry; Metallurgy 0 Active
US11492339B2 Processes for conversion of biologically derived mevalonic acid Chemistry; Metallurgy 0 Active
US12226379B2 Highly sustainable compositions for modulation of gene expression in human skin, and methods of production thereof Chemistry; Metallurgy 0 Active
US10807963B2 Processes for conversion of biologically derived mevalonic acid Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.